Companies

Antibiotics + ARVs + cardio-CNS therapies. Significant US generic and EU presence.

Indian arm of Becton, Dickinson and Company (US) — global medical-technology leader. Manufactures syringes & needles, IV catheters, biosciences instruments, diagnostic systems. Bawal (Haryana) plant is BD's largest needle and syringe facility globally.

Privately held vaccines and biologics manufacturer. Behind India's first indigenously developed COVID-19 vaccine (Covaxin) and the rotavirus vaccine Rotavac. WHO-pre-qualified facility in Genome Valley, Hyderabad.

Biopharmaceutical leader — biosimilars + insulins + research services (Syngene).

Founded in 1935 by K. A. Hamied. Strong respiratory + HIV/AIDS therapy portfolio.

API and intermediates manufacturer. Major exporter to regulated markets.

Global generics + APIs + biosimilars. Operations across 60+ countries.

Pune-headquartered specialty pharma — strong cardiovascular, gynaecology, anti-infectives, HIV/AIDS portfolios. Listed on BSE/NSE since 2024.

Branded-formulations pharma focused on chronic-therapy areas: cardio-metabolic, dermatology, women's health. Listed on BSE/NSE.

Indian arm of GE HealthCare — joint venture with Wipro since 1990. Designs and manufactures medical imaging (CT, MRI, ultrasound, X-ray), patient monitoring, and life-care equipment. JFWTC Bengaluru is GE's largest R&D centre outside the United States.

Innovation-led pharma — dermatology, respiratory, oncology pipelines.

Indian listed entity of GSK plc. Vaccines, anti-infectives, dermatology, respiratory.

Antimalarial leader globally. Branded formulations + APIs + institutional sales.

Mumbai-headquartered branded-formulations pharma. Cardiology, gastroenterology, anti-infectives. KKR-controlled since 2020. Listed on BSE/NSE.

Global pharma — large presence in US generics. Anti-TB, cardiovascular, diabetes therapies.

Mass-market focused — affordable formulations across acute and chronic. Strong tier-2/tier-3 reach.